Use of aspirin to reduce risk of initial vascular events in patients at moderate risk of cardiovascular disease (ARRIVE): a randomised, double-blind, placebo-controlled trial
<strong>Background</strong> The use of aspirin in the primary prevention of cardiovascular events remains controversial. We aimed to assess the efficacy and safety of aspirin versus placebo in patients with a moderate estimated risk of a first cardiovascular event. <strong>Methods...
Main Authors: | Gaziano, J, Brotons, C, Coppolecchia, R, Cricelli, C, Darius, H, Gorelick, P, Howard, G, Pearson, T, Rothwell, P, Ruilope, L, Tendera, M, Tognoni, G, Committee, A |
---|---|
格式: | Journal article |
语言: | English |
出版: |
Elsevier
2018
|
相似书籍
-
Effects on colon cancer risk in randomised trials of aspirin
由: Rothwell, P
出版: (2011) -
Alternate-day, low-dose aspirin and cancer risk.
由: Rothwell, P
出版: (2013) -
Risk of intracerebral hemorrhage in patients with arterial versus cardiac origin of cerebral ischemia on aspirin or placebo: analysis of individual patient data from 9 trials.
由: Ariesen, M, et al.
出版: (2004) -
Effects of aspirin on risks of vascular events and cancer according to bodyweight and dose: analysis of individual patient data from randomised trials
由: Rothwell, P, et al.
出版: (2018) -
Aspirin in prevention of sporadic colorectal cancer: current clinical evidence and overall balance of risks and benefits.
由: Rothwell, P
出版: (2013)